Tapewire

NYSE · USD

PSA

Public Storage

Export transactions ↓
Tapewire entity
1436
SEC CIK
0001393311
Parsed reports
654

Last 12 months

Inside the activity.

0 purchase rows · 2 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202601
Jul 202600
Aug 202601
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 16, 2024 Filed Feb 21, 2024 01:13 UTC
Johnson NataliaChief Administrative Officer
Tax withholdingCommon Shares 567 $281.52 $159,621.84
Disclosure

SEC source: 0001393311-24-000047 · wk-form4_1708477955.xml · nonDerivative · entry 1

Johnson Natalia · CIK 0001726283 · Chief Administrative Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,420

F1 · balance_after: Includes 11,310 restricted stock units.

Read SEC document
February 16, 2024 Filed Feb 21, 2024 01:16 UTC
Vitan Nathaniel A.Chief Legal Officer
Tax withholdingCommon Shares 333 $281.52 $93,746.16
Disclosure

SEC source: 0001393311-24-000049 · wk-form4_1708478188.xml · nonDerivative · entry 1

Vitan Nathaniel A. · CIK 0001774586 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,614

F1 · balance_after: Includes 9,250 restricted share units.

Read SEC document
February 16, 2024 Filed Feb 21, 2024 01:10 UTC
Boyle TomCFO and CIO
Tax withholdingCommon Shares 693 $281.52 $195,093.36
Disclosure

SEC source: 0001393311-24-000045 · wk-form4_1708477831.xml · nonDerivative · entry 1

Boyle Tom · CIK 0001734897 · CFO and CIO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,702

F1 · balance_after: Includes 15,475 restricted share units.

Read SEC document
February 15, 2024 Filed Feb 20, 2024 17:22 UTC GrantAO LTIP Units · Derivative 103,275 Not disclosed Not disclosed
Disclosure

SEC source: 0001393311-24-000034 · wk-form4_1708449726.xml · derivative · entry 7

HAVNER RONALD L JR · CIK 0001227384 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 103,275

Underlying: Common Shares · 103,275 shares

Expires 2024-02-19

F7 · derivative.exercise_price: In exchange for each Canceled Option, the reporting person received a replacement award of membership interests in Public Storage OP designated as AO LTIP Units ("AO LTIP Units"), which AO LTIP Units are intended to qualify as profits interests for US federal income tax purposes. The AO LTIP Units are convertible at the reporting person's election into vested LTIP Units that are convertible into OP Units. The resulting OP Units may be exchanged by the reporting person for Common Shares or the equivalent cash value of Common Shares, as determined by the Company.

F7 · price: In exchange for each Canceled Option, the reporting person received a replacement award of membership interests in Public Storage OP designated as AO LTIP Units ("AO LTIP Units"), which AO LTIP Units are intended to qualify as profits interests for US federal income tax purposes. The AO LTIP Units are convertible at the reporting person's election into vested LTIP Units that are convertible into OP Units. The resulting OP Units may be exchanged by the reporting person for Common Shares or the equivalent cash value of Common Shares, as determined by the Company.

F7 · derivative.exercise_date: In exchange for each Canceled Option, the reporting person received a replacement award of membership interests in Public Storage OP designated as AO LTIP Units ("AO LTIP Units"), which AO LTIP Units are intended to qualify as profits interests for US federal income tax purposes. The AO LTIP Units are convertible at the reporting person's election into vested LTIP Units that are convertible into OP Units. The resulting OP Units may be exchanged by the reporting person for Common Shares or the equivalent cash value of Common Shares, as determined by the Company.

Read SEC document
February 15, 2024 Filed Feb 20, 2024 17:22 UTC Disposition to issuerStock Option (Right to Buy) · Derivative 103,275 Not disclosed Strike: $161.42 Not disclosed
Disclosure

SEC source: 0001393311-24-000034 · wk-form4_1708449726.xml · derivative · entry 6

HAVNER RONALD L JR · CIK 0001227384 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 103,275 shares

Expires 2024-02-19

F6 · derivative.exercise_price: This option was previously reported as an option for 100,000 common shares at an exercise price of $166.71, but, pursuant to anti-dilution provisions of the Company's 2007 Equity and Performance-Based Incentive Compensation Plan, was adjusted to reflect the special dividend declared by the Company on July 22, 2022. On February 15, 2024, the Company canceled the option upon surrender to the Company by the reporting person (the "Canceled Option").

F6 · price: This option was previously reported as an option for 100,000 common shares at an exercise price of $166.71, but, pursuant to anti-dilution provisions of the Company's 2007 Equity and Performance-Based Incentive Compensation Plan, was adjusted to reflect the special dividend declared by the Company on July 22, 2022. On February 15, 2024, the Company canceled the option upon surrender to the Company by the reporting person (the "Canceled Option").

F6 · derivative.exercise_date: This option was previously reported as an option for 100,000 common shares at an exercise price of $166.71, but, pursuant to anti-dilution provisions of the Company's 2007 Equity and Performance-Based Incentive Compensation Plan, was adjusted to reflect the special dividend declared by the Company on July 22, 2022. On February 15, 2024, the Company canceled the option upon surrender to the Company by the reporting person (the "Canceled Option").

F6 · derivative.underlying_shares: This option was previously reported as an option for 100,000 common shares at an exercise price of $166.71, but, pursuant to anti-dilution provisions of the Company's 2007 Equity and Performance-Based Incentive Compensation Plan, was adjusted to reflect the special dividend declared by the Company on July 22, 2022. On February 15, 2024, the Company canceled the option upon surrender to the Company by the reporting person (the "Canceled Option").

Read SEC document
February 15, 2024 Filed Feb 20, 2024 17:22 UTC GrantLTIP Units · Derivative 21,875 Not disclosed Not disclosed
Disclosure

SEC source: 0001393311-24-000034 · wk-form4_1708449726.xml · derivative · entry 5

HAVNER RONALD L JR · CIK 0001227384 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,875

Underlying: Common Shares · 21,875 shares

Expires not disclosed

F5 · derivative.exercise_price: In exchange for the Canceled RSUs, the reporting person received a replacement award of membership interests in Public Storage OP, L.P. ("Public Storage OP"), a subsidiary of the Company, designated as LTIP Units ("LTIP Units"), which LTIP Units are intended to qualify as profits interests for US federal income tax purposes. The vesting schedule for each LTIP Unit is the same as the vesting schedule for the corresponding Canceled RSU. The LTIP Units, if and as they become vested, are convertible, conditioned upon the satisfaction of minimum allocations to the capital accounts of the LTIP Units for federal income tax purposes, into Common Units in Public Storage OP ("OP Units"). The resulting OP Units may be exchanged by the reporting person for Common Shares or the equivalent cash value of Common Shares, as determined by the Company.

F5 · price: In exchange for the Canceled RSUs, the reporting person received a replacement award of membership interests in Public Storage OP, L.P. ("Public Storage OP"), a subsidiary of the Company, designated as LTIP Units ("LTIP Units"), which LTIP Units are intended to qualify as profits interests for US federal income tax purposes. The vesting schedule for each LTIP Unit is the same as the vesting schedule for the corresponding Canceled RSU. The LTIP Units, if and as they become vested, are convertible, conditioned upon the satisfaction of minimum allocations to the capital accounts of the LTIP Units for federal income tax purposes, into Common Units in Public Storage OP ("OP Units"). The resulting OP Units may be exchanged by the reporting person for Common Shares or the equivalent cash value of Common Shares, as determined by the Company.

F5 · derivative.exercise_date: In exchange for the Canceled RSUs, the reporting person received a replacement award of membership interests in Public Storage OP, L.P. ("Public Storage OP"), a subsidiary of the Company, designated as LTIP Units ("LTIP Units"), which LTIP Units are intended to qualify as profits interests for US federal income tax purposes. The vesting schedule for each LTIP Unit is the same as the vesting schedule for the corresponding Canceled RSU. The LTIP Units, if and as they become vested, are convertible, conditioned upon the satisfaction of minimum allocations to the capital accounts of the LTIP Units for federal income tax purposes, into Common Units in Public Storage OP ("OP Units"). The resulting OP Units may be exchanged by the reporting person for Common Shares or the equivalent cash value of Common Shares, as determined by the Company.

F5 · derivative.expiration_date: In exchange for the Canceled RSUs, the reporting person received a replacement award of membership interests in Public Storage OP, L.P. ("Public Storage OP"), a subsidiary of the Company, designated as LTIP Units ("LTIP Units"), which LTIP Units are intended to qualify as profits interests for US federal income tax purposes. The vesting schedule for each LTIP Unit is the same as the vesting schedule for the corresponding Canceled RSU. The LTIP Units, if and as they become vested, are convertible, conditioned upon the satisfaction of minimum allocations to the capital accounts of the LTIP Units for federal income tax purposes, into Common Units in Public Storage OP ("OP Units"). The resulting OP Units may be exchanged by the reporting person for Common Shares or the equivalent cash value of Common Shares, as determined by the Company.

Read SEC document
February 15, 2024 Filed Feb 20, 2024 17:22 UTC Disposition to issuerCommon Shares 21,875 $0.00 $0.00
Disclosure

SEC source: 0001393311-24-000034 · wk-form4_1708449726.xml · nonDerivative · entry 2

HAVNER RONALD L JR · CIK 0001227384 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,548

F2 · shares: These restricted share units (the "RSUs") in respect of common shares, par value $0.10 per share ("Common Shares"), of Public Storage (the "Company") were previously granted to the reporting person and provided for time-based vesting. On February 15, 2024, the Company canceled the unvested RSUs upon surrender to the Company by the reporting person (the "Canceled RSUs").

F3 · balance_after: Includes 5,000 restricted share units and 2,306 deferred share units. Mr. Havner postponed receipt of 10,000 vested restricted share units granted February 19, 2015 with an original vesting date of April 1, 2016 in accordance with the following schedule: 10 equal installments over 10 years starting April 1, 2021 to April 1, 2030. 7,000 remain subject to deferred receipt and are also included here.

Read SEC document
February 15, 2024 Filed Feb 20, 2024 17:22 UTC Tax withholdingCommon Shares 1,008 $286.26 $288,550.08
Disclosure

SEC source: 0001393311-24-000034 · wk-form4_1708449726.xml · nonDerivative · entry 1

HAVNER RONALD L JR · CIK 0001227384 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,423

F1 · balance_after: Includes 26,875 restricted share units and 2,306 deferred share units. Mr. Havner postponed receipt of 10,000 vested restricted share units granted February 19, 2015 with an original vesting date of April 1, 2016 in accordance with the following schedule: 10 equal installments over 10 years starting April 1, 2021 to April 1, 2030. 7,000 remain subject to deferred receipt and are also included here.

Read SEC document
February 15, 2024 Filed Feb 20, 2024 12:25 UTC
REYES JOHNDirector
GrantLTIP Units · Derivative 15,500 Not disclosed Not disclosed
Disclosure

SEC source: 0001393311-24-000036 · wk-form4_1708449903.xml · derivative · entry 3

REYES JOHN · CIK 0001227389 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,500

Underlying: Common Shares · 15,500 shares

Expires not disclosed

F5 · derivative.exercise_price: In exchange for the Canceled RSUs, the reporting person received a replacement award of membership interests in Public Storage OP, L.P. ("Public Storage OP"), a subsidiary of the Company, designated as LTIP Units ("LTIP Units"), which LTIP Units are intended to qualify as profits interests for US federal income tax purposes. The vesting schedule for each LTIP Unit is the same as the vesting schedule for the corresponding Canceled RSU. The LTIP Units, if and as they become vested, are convertible, conditioned upon the satisfaction of minimum allocations to the capital accounts of the LTIP Units for federal income tax purposes, into Common Units in Public Storage OP ("OP Units"). The resulting OP Units may be exchanged by the reporting person for Common Shares or the equivalent cash value of Common Shares, as determined by the Company.

F5 · price: In exchange for the Canceled RSUs, the reporting person received a replacement award of membership interests in Public Storage OP, L.P. ("Public Storage OP"), a subsidiary of the Company, designated as LTIP Units ("LTIP Units"), which LTIP Units are intended to qualify as profits interests for US federal income tax purposes. The vesting schedule for each LTIP Unit is the same as the vesting schedule for the corresponding Canceled RSU. The LTIP Units, if and as they become vested, are convertible, conditioned upon the satisfaction of minimum allocations to the capital accounts of the LTIP Units for federal income tax purposes, into Common Units in Public Storage OP ("OP Units"). The resulting OP Units may be exchanged by the reporting person for Common Shares or the equivalent cash value of Common Shares, as determined by the Company.

F5 · derivative.exercise_date: In exchange for the Canceled RSUs, the reporting person received a replacement award of membership interests in Public Storage OP, L.P. ("Public Storage OP"), a subsidiary of the Company, designated as LTIP Units ("LTIP Units"), which LTIP Units are intended to qualify as profits interests for US federal income tax purposes. The vesting schedule for each LTIP Unit is the same as the vesting schedule for the corresponding Canceled RSU. The LTIP Units, if and as they become vested, are convertible, conditioned upon the satisfaction of minimum allocations to the capital accounts of the LTIP Units for federal income tax purposes, into Common Units in Public Storage OP ("OP Units"). The resulting OP Units may be exchanged by the reporting person for Common Shares or the equivalent cash value of Common Shares, as determined by the Company.

F5 · derivative.expiration_date: In exchange for the Canceled RSUs, the reporting person received a replacement award of membership interests in Public Storage OP, L.P. ("Public Storage OP"), a subsidiary of the Company, designated as LTIP Units ("LTIP Units"), which LTIP Units are intended to qualify as profits interests for US federal income tax purposes. The vesting schedule for each LTIP Unit is the same as the vesting schedule for the corresponding Canceled RSU. The LTIP Units, if and as they become vested, are convertible, conditioned upon the satisfaction of minimum allocations to the capital accounts of the LTIP Units for federal income tax purposes, into Common Units in Public Storage OP ("OP Units"). The resulting OP Units may be exchanged by the reporting person for Common Shares or the equivalent cash value of Common Shares, as determined by the Company.

Read SEC document
February 15, 2024 Filed Feb 20, 2024 12:25 UTC
REYES JOHNDirector
Disposition to issuerCommon Shares 15,500 $0.00 $0.00
Disclosure

SEC source: 0001393311-24-000036 · wk-form4_1708449903.xml · nonDerivative · entry 1

REYES JOHN · CIK 0001227389 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,251

F1 · shares: These restricted share units (the "RSUs") in respect of common shares, par value $0.10 per share ("Common Shares"), of Public Storage (the "Company") were previously granted to the reporting person and provided for time-based vesting. On February 15, 2024, the Company canceled the unvested RSUs upon surrender to the Company by the reporting person (the "Canceled RSUs").

F2 · balance_after: Includes 1,800 restricted share units and 2,306 deferred share units.

Read SEC document
February 05, 2024 Filed Feb 7, 2024 22:16 UTC
Johnson NataliaChief Administrative Officer
GrantStock Option (Right to Buy) · Derivative 77,456 $0.00 Strike: $222.66 $0.00
Disclosure

SEC source: 0001393311-24-000026 · wk-form4_1707344175.xml · derivative · entry 1

Johnson Natalia · CIK 0001726283 · Chief Administrative Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 77,456

Underlying: Common Shares · 77,456 shares

Expires 2031-02-16

F1 · security: Reflects an award of performance-based stock options originally granted February 16, 2021, subject to a three year (2021-2023) performance period. As originally granted, this award was for 50,000 options (at target) with an exercise price of $229.95 per share. Pursuant to anti-dilution provisions of the Company's 2016 Equity and Performance-Based Incentive Compensation Plan, these options were adjusted to reflect the special dividend declared by the Company on July 22, 2022. On February 5, 2024, following completion of the performance period, the Compensation and Human Capital Committee certified performance at 150% of target, as reflected here. Three-fifths of these options will vest on February 16, 2024, with the remaining vesting ratably over the next two years.

F1 · derivative.exercise_price: Reflects an award of performance-based stock options originally granted February 16, 2021, subject to a three year (2021-2023) performance period. As originally granted, this award was for 50,000 options (at target) with an exercise price of $229.95 per share. Pursuant to anti-dilution provisions of the Company's 2016 Equity and Performance-Based Incentive Compensation Plan, these options were adjusted to reflect the special dividend declared by the Company on July 22, 2022. On February 5, 2024, following completion of the performance period, the Compensation and Human Capital Committee certified performance at 150% of target, as reflected here. Three-fifths of these options will vest on February 16, 2024, with the remaining vesting ratably over the next two years.

F1 · date: Reflects an award of performance-based stock options originally granted February 16, 2021, subject to a three year (2021-2023) performance period. As originally granted, this award was for 50,000 options (at target) with an exercise price of $229.95 per share. Pursuant to anti-dilution provisions of the Company's 2016 Equity and Performance-Based Incentive Compensation Plan, these options were adjusted to reflect the special dividend declared by the Company on July 22, 2022. On February 5, 2024, following completion of the performance period, the Compensation and Human Capital Committee certified performance at 150% of target, as reflected here. Three-fifths of these options will vest on February 16, 2024, with the remaining vesting ratably over the next two years.

F1 · shares: Reflects an award of performance-based stock options originally granted February 16, 2021, subject to a three year (2021-2023) performance period. As originally granted, this award was for 50,000 options (at target) with an exercise price of $229.95 per share. Pursuant to anti-dilution provisions of the Company's 2016 Equity and Performance-Based Incentive Compensation Plan, these options were adjusted to reflect the special dividend declared by the Company on July 22, 2022. On February 5, 2024, following completion of the performance period, the Compensation and Human Capital Committee certified performance at 150% of target, as reflected here. Three-fifths of these options will vest on February 16, 2024, with the remaining vesting ratably over the next two years.

F1 · derivative.exercise_date: Reflects an award of performance-based stock options originally granted February 16, 2021, subject to a three year (2021-2023) performance period. As originally granted, this award was for 50,000 options (at target) with an exercise price of $229.95 per share. Pursuant to anti-dilution provisions of the Company's 2016 Equity and Performance-Based Incentive Compensation Plan, these options were adjusted to reflect the special dividend declared by the Company on July 22, 2022. On February 5, 2024, following completion of the performance period, the Compensation and Human Capital Committee certified performance at 150% of target, as reflected here. Three-fifths of these options will vest on February 16, 2024, with the remaining vesting ratably over the next two years.

F1 · derivative.expiration_date: Reflects an award of performance-based stock options originally granted February 16, 2021, subject to a three year (2021-2023) performance period. As originally granted, this award was for 50,000 options (at target) with an exercise price of $229.95 per share. Pursuant to anti-dilution provisions of the Company's 2016 Equity and Performance-Based Incentive Compensation Plan, these options were adjusted to reflect the special dividend declared by the Company on July 22, 2022. On February 5, 2024, following completion of the performance period, the Compensation and Human Capital Committee certified performance at 150% of target, as reflected here. Three-fifths of these options will vest on February 16, 2024, with the remaining vesting ratably over the next two years.

F1 · derivative.underlying_shares: Reflects an award of performance-based stock options originally granted February 16, 2021, subject to a three year (2021-2023) performance period. As originally granted, this award was for 50,000 options (at target) with an exercise price of $229.95 per share. Pursuant to anti-dilution provisions of the Company's 2016 Equity and Performance-Based Incentive Compensation Plan, these options were adjusted to reflect the special dividend declared by the Company on July 22, 2022. On February 5, 2024, following completion of the performance period, the Compensation and Human Capital Committee certified performance at 150% of target, as reflected here. Three-fifths of these options will vest on February 16, 2024, with the remaining vesting ratably over the next two years.

F1 · balance_after: Reflects an award of performance-based stock options originally granted February 16, 2021, subject to a three year (2021-2023) performance period. As originally granted, this award was for 50,000 options (at target) with an exercise price of $229.95 per share. Pursuant to anti-dilution provisions of the Company's 2016 Equity and Performance-Based Incentive Compensation Plan, these options were adjusted to reflect the special dividend declared by the Company on July 22, 2022. On February 5, 2024, following completion of the performance period, the Compensation and Human Capital Committee certified performance at 150% of target, as reflected here. Three-fifths of these options will vest on February 16, 2024, with the remaining vesting ratably over the next two years.

Read SEC document
February 05, 2024 Filed Feb 7, 2024 17:17 UTC
RUSSELL JOSEPH D JRDirector · President and CEO
GrantStock Option (Right to Buy) · Derivative 123,930 $0.00 Strike: $222.66 $0.00
Disclosure

SEC source: 0001393311-24-000028 · wk-form4_1707344264.xml · derivative · entry 1

RUSSELL JOSEPH D JR · CIK 0001230471 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 123,930

Underlying: Common Shares · 123,930 shares

Expires 2031-02-16

F1 · security: Reflects an award of performance-based stock options originally granted February 16, 2021, subject to a three year (2021-2023) performance period. As originally granted, this award was for 80,000 options (at target) with an exercise price of $229.95 per share. Pursuant to anti-dilution provisions of the Company's 2016 Equity and Performance-Based Incentive Compensation Plan, these options were adjusted to reflect the special dividend declared by the Company on July 22, 2022. On February 5, 2024, following completion of the performance period, the Compensation and Human Capital Committee certified performance at 150% of target, as reflected here. Three-fifths of these options will vest on February 16, 2024, with the remaining vesting ratably over the next two years.

F1 · derivative.exercise_price: Reflects an award of performance-based stock options originally granted February 16, 2021, subject to a three year (2021-2023) performance period. As originally granted, this award was for 80,000 options (at target) with an exercise price of $229.95 per share. Pursuant to anti-dilution provisions of the Company's 2016 Equity and Performance-Based Incentive Compensation Plan, these options were adjusted to reflect the special dividend declared by the Company on July 22, 2022. On February 5, 2024, following completion of the performance period, the Compensation and Human Capital Committee certified performance at 150% of target, as reflected here. Three-fifths of these options will vest on February 16, 2024, with the remaining vesting ratably over the next two years.

F1 · date: Reflects an award of performance-based stock options originally granted February 16, 2021, subject to a three year (2021-2023) performance period. As originally granted, this award was for 80,000 options (at target) with an exercise price of $229.95 per share. Pursuant to anti-dilution provisions of the Company's 2016 Equity and Performance-Based Incentive Compensation Plan, these options were adjusted to reflect the special dividend declared by the Company on July 22, 2022. On February 5, 2024, following completion of the performance period, the Compensation and Human Capital Committee certified performance at 150% of target, as reflected here. Three-fifths of these options will vest on February 16, 2024, with the remaining vesting ratably over the next two years.

F1 · shares: Reflects an award of performance-based stock options originally granted February 16, 2021, subject to a three year (2021-2023) performance period. As originally granted, this award was for 80,000 options (at target) with an exercise price of $229.95 per share. Pursuant to anti-dilution provisions of the Company's 2016 Equity and Performance-Based Incentive Compensation Plan, these options were adjusted to reflect the special dividend declared by the Company on July 22, 2022. On February 5, 2024, following completion of the performance period, the Compensation and Human Capital Committee certified performance at 150% of target, as reflected here. Three-fifths of these options will vest on February 16, 2024, with the remaining vesting ratably over the next two years.

F1 · derivative.exercise_date: Reflects an award of performance-based stock options originally granted February 16, 2021, subject to a three year (2021-2023) performance period. As originally granted, this award was for 80,000 options (at target) with an exercise price of $229.95 per share. Pursuant to anti-dilution provisions of the Company's 2016 Equity and Performance-Based Incentive Compensation Plan, these options were adjusted to reflect the special dividend declared by the Company on July 22, 2022. On February 5, 2024, following completion of the performance period, the Compensation and Human Capital Committee certified performance at 150% of target, as reflected here. Three-fifths of these options will vest on February 16, 2024, with the remaining vesting ratably over the next two years.

F1 · derivative.expiration_date: Reflects an award of performance-based stock options originally granted February 16, 2021, subject to a three year (2021-2023) performance period. As originally granted, this award was for 80,000 options (at target) with an exercise price of $229.95 per share. Pursuant to anti-dilution provisions of the Company's 2016 Equity and Performance-Based Incentive Compensation Plan, these options were adjusted to reflect the special dividend declared by the Company on July 22, 2022. On February 5, 2024, following completion of the performance period, the Compensation and Human Capital Committee certified performance at 150% of target, as reflected here. Three-fifths of these options will vest on February 16, 2024, with the remaining vesting ratably over the next two years.

F1 · derivative.underlying_shares: Reflects an award of performance-based stock options originally granted February 16, 2021, subject to a three year (2021-2023) performance period. As originally granted, this award was for 80,000 options (at target) with an exercise price of $229.95 per share. Pursuant to anti-dilution provisions of the Company's 2016 Equity and Performance-Based Incentive Compensation Plan, these options were adjusted to reflect the special dividend declared by the Company on July 22, 2022. On February 5, 2024, following completion of the performance period, the Compensation and Human Capital Committee certified performance at 150% of target, as reflected here. Three-fifths of these options will vest on February 16, 2024, with the remaining vesting ratably over the next two years.

F1 · balance_after: Reflects an award of performance-based stock options originally granted February 16, 2021, subject to a three year (2021-2023) performance period. As originally granted, this award was for 80,000 options (at target) with an exercise price of $229.95 per share. Pursuant to anti-dilution provisions of the Company's 2016 Equity and Performance-Based Incentive Compensation Plan, these options were adjusted to reflect the special dividend declared by the Company on July 22, 2022. On February 5, 2024, following completion of the performance period, the Compensation and Human Capital Committee certified performance at 150% of target, as reflected here. Three-fifths of these options will vest on February 16, 2024, with the remaining vesting ratably over the next two years.

Read SEC document
February 05, 2024 Filed Feb 7, 2024 22:19 UTC
Vitan Nathaniel A.Chief Legal Officer
GrantStock Option (Right to Buy) · Derivative 77,456 $0.00 Strike: $222.66 $0.00
Disclosure

SEC source: 0001393311-24-000030 · wk-form4_1707344334.xml · derivative · entry 1

Vitan Nathaniel A. · CIK 0001774586 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 77,456

Underlying: Common Shares · 77,456 shares

Expires 2031-02-16

F1 · security: Reflects an award of performance-based stock options originally granted February 16, 2021, subject to a three year (2021-2023) performance period. As originally granted, this award was for 50,000 options (at target) with an exercise price of $229.95 per share. Pursuant to anti-dilution provisions of the Company's 2016 Equity and Performance-Based Incentive Compensation Plan, these options were adjusted to reflect the special dividend declared by the Company on July 22, 2022. On February 5, 2024, following completion of the performance period, the Compensation and Human Capital Committee certified performance at 150% of target, as reflected here. Three-fifths of these options will vest on February 16, 2024, with the remaining vesting ratably over the next two years.

F1 · derivative.exercise_price: Reflects an award of performance-based stock options originally granted February 16, 2021, subject to a three year (2021-2023) performance period. As originally granted, this award was for 50,000 options (at target) with an exercise price of $229.95 per share. Pursuant to anti-dilution provisions of the Company's 2016 Equity and Performance-Based Incentive Compensation Plan, these options were adjusted to reflect the special dividend declared by the Company on July 22, 2022. On February 5, 2024, following completion of the performance period, the Compensation and Human Capital Committee certified performance at 150% of target, as reflected here. Three-fifths of these options will vest on February 16, 2024, with the remaining vesting ratably over the next two years.

F1 · date: Reflects an award of performance-based stock options originally granted February 16, 2021, subject to a three year (2021-2023) performance period. As originally granted, this award was for 50,000 options (at target) with an exercise price of $229.95 per share. Pursuant to anti-dilution provisions of the Company's 2016 Equity and Performance-Based Incentive Compensation Plan, these options were adjusted to reflect the special dividend declared by the Company on July 22, 2022. On February 5, 2024, following completion of the performance period, the Compensation and Human Capital Committee certified performance at 150% of target, as reflected here. Three-fifths of these options will vest on February 16, 2024, with the remaining vesting ratably over the next two years.

F1 · shares: Reflects an award of performance-based stock options originally granted February 16, 2021, subject to a three year (2021-2023) performance period. As originally granted, this award was for 50,000 options (at target) with an exercise price of $229.95 per share. Pursuant to anti-dilution provisions of the Company's 2016 Equity and Performance-Based Incentive Compensation Plan, these options were adjusted to reflect the special dividend declared by the Company on July 22, 2022. On February 5, 2024, following completion of the performance period, the Compensation and Human Capital Committee certified performance at 150% of target, as reflected here. Three-fifths of these options will vest on February 16, 2024, with the remaining vesting ratably over the next two years.

F1 · derivative.exercise_date: Reflects an award of performance-based stock options originally granted February 16, 2021, subject to a three year (2021-2023) performance period. As originally granted, this award was for 50,000 options (at target) with an exercise price of $229.95 per share. Pursuant to anti-dilution provisions of the Company's 2016 Equity and Performance-Based Incentive Compensation Plan, these options were adjusted to reflect the special dividend declared by the Company on July 22, 2022. On February 5, 2024, following completion of the performance period, the Compensation and Human Capital Committee certified performance at 150% of target, as reflected here. Three-fifths of these options will vest on February 16, 2024, with the remaining vesting ratably over the next two years.

F1 · derivative.expiration_date: Reflects an award of performance-based stock options originally granted February 16, 2021, subject to a three year (2021-2023) performance period. As originally granted, this award was for 50,000 options (at target) with an exercise price of $229.95 per share. Pursuant to anti-dilution provisions of the Company's 2016 Equity and Performance-Based Incentive Compensation Plan, these options were adjusted to reflect the special dividend declared by the Company on July 22, 2022. On February 5, 2024, following completion of the performance period, the Compensation and Human Capital Committee certified performance at 150% of target, as reflected here. Three-fifths of these options will vest on February 16, 2024, with the remaining vesting ratably over the next two years.

F1 · derivative.underlying_shares: Reflects an award of performance-based stock options originally granted February 16, 2021, subject to a three year (2021-2023) performance period. As originally granted, this award was for 50,000 options (at target) with an exercise price of $229.95 per share. Pursuant to anti-dilution provisions of the Company's 2016 Equity and Performance-Based Incentive Compensation Plan, these options were adjusted to reflect the special dividend declared by the Company on July 22, 2022. On February 5, 2024, following completion of the performance period, the Compensation and Human Capital Committee certified performance at 150% of target, as reflected here. Three-fifths of these options will vest on February 16, 2024, with the remaining vesting ratably over the next two years.

F1 · balance_after: Reflects an award of performance-based stock options originally granted February 16, 2021, subject to a three year (2021-2023) performance period. As originally granted, this award was for 50,000 options (at target) with an exercise price of $229.95 per share. Pursuant to anti-dilution provisions of the Company's 2016 Equity and Performance-Based Incentive Compensation Plan, these options were adjusted to reflect the special dividend declared by the Company on July 22, 2022. On February 5, 2024, following completion of the performance period, the Compensation and Human Capital Committee certified performance at 150% of target, as reflected here. Three-fifths of these options will vest on February 16, 2024, with the remaining vesting ratably over the next two years.

Read SEC document
February 05, 2024 Filed Feb 7, 2024 22:15 UTC
Boyle TomCFO and CIO
GrantStock Option (Right to Buy) · Derivative 100,692 $0.00 Strike: $222.66 $0.00
Disclosure

SEC source: 0001393311-24-000024 · wk-form4_1707344089.xml · derivative · entry 1

Boyle Tom · CIK 0001734897 · CFO and CIO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,692

Underlying: Common Shares · 100,692 shares

Expires 2031-02-16

F1 · security: Reflects an award of performance-based stock options originally granted February 16, 2021, subject to a three year (2021-2023) performance period. As originally granted, this award was for 65,000 options (at target) with an exercise price of $229.95 per share. Pursuant to anti-dilution provisions of the Company's 2016 Equity and Performance-Based Incentive Compensation Plan, these options were adjusted to reflect the special dividend declared by the Company on July 22, 2022. On February 5, 2024, following completion of the performance period, the Compensation and Human Capital Committee certified performance at 150% of target, as reflected here. Three-fifths of these options will vest on February 16, 2024, with the remaining vesting ratably over the next two years.

F1 · derivative.exercise_price: Reflects an award of performance-based stock options originally granted February 16, 2021, subject to a three year (2021-2023) performance period. As originally granted, this award was for 65,000 options (at target) with an exercise price of $229.95 per share. Pursuant to anti-dilution provisions of the Company's 2016 Equity and Performance-Based Incentive Compensation Plan, these options were adjusted to reflect the special dividend declared by the Company on July 22, 2022. On February 5, 2024, following completion of the performance period, the Compensation and Human Capital Committee certified performance at 150% of target, as reflected here. Three-fifths of these options will vest on February 16, 2024, with the remaining vesting ratably over the next two years.

F1 · date: Reflects an award of performance-based stock options originally granted February 16, 2021, subject to a three year (2021-2023) performance period. As originally granted, this award was for 65,000 options (at target) with an exercise price of $229.95 per share. Pursuant to anti-dilution provisions of the Company's 2016 Equity and Performance-Based Incentive Compensation Plan, these options were adjusted to reflect the special dividend declared by the Company on July 22, 2022. On February 5, 2024, following completion of the performance period, the Compensation and Human Capital Committee certified performance at 150% of target, as reflected here. Three-fifths of these options will vest on February 16, 2024, with the remaining vesting ratably over the next two years.

F1 · shares: Reflects an award of performance-based stock options originally granted February 16, 2021, subject to a three year (2021-2023) performance period. As originally granted, this award was for 65,000 options (at target) with an exercise price of $229.95 per share. Pursuant to anti-dilution provisions of the Company's 2016 Equity and Performance-Based Incentive Compensation Plan, these options were adjusted to reflect the special dividend declared by the Company on July 22, 2022. On February 5, 2024, following completion of the performance period, the Compensation and Human Capital Committee certified performance at 150% of target, as reflected here. Three-fifths of these options will vest on February 16, 2024, with the remaining vesting ratably over the next two years.

F1 · derivative.exercise_date: Reflects an award of performance-based stock options originally granted February 16, 2021, subject to a three year (2021-2023) performance period. As originally granted, this award was for 65,000 options (at target) with an exercise price of $229.95 per share. Pursuant to anti-dilution provisions of the Company's 2016 Equity and Performance-Based Incentive Compensation Plan, these options were adjusted to reflect the special dividend declared by the Company on July 22, 2022. On February 5, 2024, following completion of the performance period, the Compensation and Human Capital Committee certified performance at 150% of target, as reflected here. Three-fifths of these options will vest on February 16, 2024, with the remaining vesting ratably over the next two years.

F1 · derivative.expiration_date: Reflects an award of performance-based stock options originally granted February 16, 2021, subject to a three year (2021-2023) performance period. As originally granted, this award was for 65,000 options (at target) with an exercise price of $229.95 per share. Pursuant to anti-dilution provisions of the Company's 2016 Equity and Performance-Based Incentive Compensation Plan, these options were adjusted to reflect the special dividend declared by the Company on July 22, 2022. On February 5, 2024, following completion of the performance period, the Compensation and Human Capital Committee certified performance at 150% of target, as reflected here. Three-fifths of these options will vest on February 16, 2024, with the remaining vesting ratably over the next two years.

F1 · derivative.underlying_shares: Reflects an award of performance-based stock options originally granted February 16, 2021, subject to a three year (2021-2023) performance period. As originally granted, this award was for 65,000 options (at target) with an exercise price of $229.95 per share. Pursuant to anti-dilution provisions of the Company's 2016 Equity and Performance-Based Incentive Compensation Plan, these options were adjusted to reflect the special dividend declared by the Company on July 22, 2022. On February 5, 2024, following completion of the performance period, the Compensation and Human Capital Committee certified performance at 150% of target, as reflected here. Three-fifths of these options will vest on February 16, 2024, with the remaining vesting ratably over the next two years.

F1 · balance_after: Reflects an award of performance-based stock options originally granted February 16, 2021, subject to a three year (2021-2023) performance period. As originally granted, this award was for 65,000 options (at target) with an exercise price of $229.95 per share. Pursuant to anti-dilution provisions of the Company's 2016 Equity and Performance-Based Incentive Compensation Plan, these options were adjusted to reflect the special dividend declared by the Company on July 22, 2022. On February 5, 2024, following completion of the performance period, the Compensation and Human Capital Committee certified performance at 150% of target, as reflected here. Three-fifths of these options will vest on February 16, 2024, with the remaining vesting ratably over the next two years.

Read SEC document
December 31, 2023 Filed Jan 4, 2024 00:01 UTC GrantCommon Shares 115 $305.00 $35,075.00
Disclosure

SEC source: 0001393311-24-000006 · wk-form4_1704326457.xml · nonDerivative · entry 1

SPOGLI RONALD P · CIK 0000916867 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,235

F1 · shares: Grant of fully-vested deferred share units pursuant to the Company's Non-Management Trustee Compensation and Deferral Program under the Company's 2021 Equity and Performance-Based Incentive Compensation Plan. Each deferred share unit represents the right to receive one Company common share. The number of deferred share units granted represents the quotient of the dollar amount of the portion of the cash retainers Mr. Spogli has earned for the applicable calendar quarter and elected to be paid in deferred share units, divided by the Company's closing share price on the grant date, rounded up to the nearest deferred share unit. The deferred share units will be settled in unrestricted common shares (i) in a lump sum on January 1st of the calendar year following Mr. Spogli's separation from service as a trustee or (ii) in a lump sum upon Mr. Spogli's earlier death or disability or upon an earlier change of control of the Company.

F2 · balance_after: Includes 2,072 deferred stock units.

Read SEC document
December 31, 2023 Filed Jan 4, 2024 00:05 UTC GrantCommon Shares 61 $305.00 $18,605.00
Disclosure

SEC source: 0001393311-24-000010 · wk-form4_1704326747.xml · nonDerivative · entry 1

WILLIAMS PAUL S · CIK 0001236458 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 835

F1 · shares: Grant of fully-vested deferred share units pursuant to the Company's Non-Management Trustee Compensation and Deferral Program under the Company's 2021 Equity and Performance-Based Incentive Compensation Plan. Each deferred share unit represents the right to receive one Company common share. The number of deferred share units granted represents the quotient of the dollar amount of the portion of the cash retainers the reporting person has earned for the applicable calendar quarter and elected to be paid in deferred share units, divided by the Company's closing share price on the grant date, rounded up to the nearest deferred share unit. The deferred share units will be settled in unrestricted common shares (i) in a lump sum following the reporting person's separation from service as a trustee or (ii) in a lump sum upon the reporting person's earlier death or disability or upon an earlier change of control of the Company.

F2 · balance_after: Includes 835 deferred share units.

Read SEC document
December 31, 2023 Filed Jan 3, 2024 23:55 UTC GrantCommon Shares 99 $305.00 $30,195.00
Disclosure

SEC source: 0001393311-24-000002 · wk-form4_1704326111.xml · nonDerivative · entry 1

HAVNER RONALD L JR · CIK 0001227384 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,431

F1 · shares: Grant of fully-vested deferred share units pursuant to the Company's Non-Management Trustee Compensation and Deferral Program under the Company's 2021 Equity and Performance-Based Incentive Compensation Plan. Each deferred share unit represents the right to receive one Company common share. The number of deferred share units granted represents the quotient of the dollar amount of the portion of the cash retainers the reporting person has earned for the applicable calendar quarter and elected to be paid in deferred share units, divided by the Company's closing share price on the grant date, rounded up to the nearest deferred share unit. The deferred share units will be settled in unrestricted common shares (i) in a lump sum upon the reporting person's separation from service as a trustee or (ii) in a lump sum upon the reporting person's earlier death or disability or upon an earlier change of control of the Company.

F2 · balance_after: Includes 33,125 restricted share units and 2,306 deferred share units. Mr. Havner postponed receipt of 10,000 vested restricted share units granted February 19, 2015 with an original vesting date of April 1, 2016 in accordance with the following schedule: 10 equal installments over 10 years starting April 1, 2021 to April 1, 2030. 7,000 remain subject to deferred receipt and are also included here.

Read SEC document
December 31, 2023 Filed Jan 3, 2024 18:59 UTC
REYES JOHNDirector
GrantCommon Shares 99 $305.00 $30,195.00
Disclosure

SEC source: 0001393311-24-000004 · wk-form4_1704326342.xml · nonDerivative · entry 1

REYES JOHN · CIK 0001227389 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 174,291

F1 · shares: Grant of fully-vested deferred share units pursuant to the Company's Non-Management Trustee Compensation and Deferral Program under the Company's 2021 Equity and Performance-Based Incentive Compensation Plan. Each deferred share unit represents the right to receive one Company common share. The number of deferred share units granted represents the quotient of the dollar amount of the portion of the cash retainers the reporting person has earned for the applicable calendar quarter and elected to be paid in deferred share units, divided by the Company's closing share price on the grant date, rounded up to the nearest deferred share unit. The deferred share units will be settled in unrestricted common shares (i) in a lump sum upon the reporting person's separation from service as a trustee or (ii) in a lump sum upon the reporting person's earlier death or disability or upon an earlier change of control of the Company.

F2 · balance_after: Includes 17,300 restricted share units and 2,306 deferred share units.

Read SEC document
December 31, 2023 Filed Jan 4, 2024 00:04 UTC GrantCommon Shares 121 $305.00 $36,905.00
Disclosure

SEC source: 0001393311-24-000008 · wk-form4_1704326607.xml · nonDerivative · entry 1

NEITHERCUT DAVID J · CIK 0001219726 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,529

F1 · shares: Grant of fully-vested deferred share units pursuant to the Company's Non-Management Trustee Compensation and Deferral Program under the Company's 2021 Equity and Performance-Based Incentive Compensation Plan. Each deferred share unit represents the right to receive one Company common share. The number of deferred share units granted represents the quotient of the dollar amount of the portion of the cash retainers the reporting person has earned for the applicable calendar quarter and elected to be paid in deferred share units, divided by the Company's closing share price on the grant date, rounded up to the nearest deferred share unit. The deferred share units will be settled in unrestricted common shares (i) in a lump sum on January 1st of the calendar year following the tenth anniversary of the grant date or (ii) in a lump sum upon the reporting person's earlier death or disability or upon an earlier change of control of the Company.

F2 · balance_after: Includes 1,529 deferred share units.

Read SEC document
December 31, 2023 Filed Jan 4, 2024 00:08 UTC GrantCommon Shares 105 $305.00 $32,025.00
Disclosure

SEC source: 0001393311-24-000012 · wk-form4_1704326873.xml · nonDerivative · entry 1

Owen Rebecca L · CIK 0001331684 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 874

F1 · shares: Grant of unrestricted Company common shares pursuant to the Company's Non-Management Trustee Compensation and Deferral Program under the Company's 2021 Equity and Performance-Based Incentive Compensation Plan. The number of shares granted represents the quotient of the dollar amount of the portion of the cash retainers the reporting person has earned for the applicable calendar quarter and elected to be paid in common shares, divided by the Company's closing share price on the grant date, rounded up to the nearest share.

Read SEC document
December 31, 2023 Filed Jan 4, 2024 00:14 UTC
Vitan Nathaniel A.Chief Legal Officer
Tax withholdingCommon Shares 41 $305.00 $12,505.00
Disclosure

SEC source: 0001393311-24-000018 · wk-form4_1704327257.xml · nonDerivative · entry 2

Vitan Nathaniel A. · CIK 0001774586 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,947

F2 · balance_after: Includes 10,150 restricted share units.

Read SEC document
December 31, 2023 Filed Jan 4, 2024 00:14 UTC
Vitan Nathaniel A.Chief Legal Officer
Tax withholdingCommon Shares 33 $305.00 $10,065.00
Disclosure

SEC source: 0001393311-24-000018 · wk-form4_1704327257.xml · nonDerivative · entry 1

Vitan Nathaniel A. · CIK 0001774586 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,988

F1 · balance_after: Includes 10,250 restricted share units.

Read SEC document
December 31, 2023 Filed Jan 4, 2024 00:12 UTC
Boyle TomCFO and CIO
Tax withholdingCommon Shares 84 $305.00 $25,620.00
Disclosure

SEC source: 0001393311-24-000016 · wk-form4_1704327118.xml · nonDerivative · entry 1

Boyle Tom · CIK 0001734897 · CFO and CIO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,395

F1 · balance_after: Includes 16,825 restricted share units.

Read SEC document
December 31, 2023 Filed Jan 4, 2024 00:10 UTC
Mitra ShankhDirector
GrantCommon Shares 105 $305.00 $32,025.00
Disclosure

SEC source: 0001393311-24-000014 · wk-form4_1704326988.xml · nonDerivative · entry 1

Mitra Shankh · CIK 0001698445 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,995

F1 · shares: Grant of unrestricted Company common shares pursuant to the Company's Non-Management Trustee Compensation and Deferral Program under the Company's 2021 Equity and Performance-Based Incentive Compensation Plan. The number of shares granted represents the quotient of the dollar amount of the portion of the cash retainers the reporting person has earned for the applicable calendar quarter and elected to be paid in common shares, divided by the Company's closing share price on the grant date, rounded up to the nearest share.

F2 · balance_after: Includes 432 deferred share units.

Read SEC document
December 13, 2023 Filed Dec 15, 2023 15:57 UTC
Vitan Nathaniel A.Chief Legal Officer
SaleCommon Shares 265 $282.17 $74,775.05
Disclosure

SEC source: 0001393311-23-000108 · wk-form4_1702655840.xml · nonDerivative · entry 1

Vitan Nathaniel A. · CIK 0001774586 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,021

F1 · balance_after: Includes 10,330 restricted stock units.

Read SEC document
December 12, 2023 Filed Dec 12, 2023 20:25 UTC
REYES JOHNDirector
Exercise / conversionStock Option (Right to Buy) · Derivative 53,275 $0.00 Strike: $161.42 $0.00
Disclosure

SEC source: 0001393311-23-000106 · wk-form4_1702430707.xml · derivative · entry 4

REYES JOHN · CIK 0001227389 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 53,275 shares

Expires 2024-02-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · security: Stock option granted pursuant to the 2007 Equity and Performance-Based Incentive Compensation Plan. Option vests in five (5) equal annual installments beginning one (1) year from grant date.

F5 · derivative.exercise_price: This option was previously reported as an option for 100,000 common shares at an exercise price of $166.71, but, pursuant to anti-dilution provisions of the Company's 2007 Equity and Performance-Based Incentive Compensation Plan, was adjusted to reflect the special dividend declared by the Company on July 22, 2022. Of the 103,275 common shares underlying the as-adjusted option, the reporting person previously reported the exercise of this option as to 50,000 common shares, and the exercise reported on this Form 4 reflects the exercise of the remainder of the option.

F5 · shares: This option was previously reported as an option for 100,000 common shares at an exercise price of $166.71, but, pursuant to anti-dilution provisions of the Company's 2007 Equity and Performance-Based Incentive Compensation Plan, was adjusted to reflect the special dividend declared by the Company on July 22, 2022. Of the 103,275 common shares underlying the as-adjusted option, the reporting person previously reported the exercise of this option as to 50,000 common shares, and the exercise reported on this Form 4 reflects the exercise of the remainder of the option.

F5 · derivative.underlying_shares: This option was previously reported as an option for 100,000 common shares at an exercise price of $166.71, but, pursuant to anti-dilution provisions of the Company's 2007 Equity and Performance-Based Incentive Compensation Plan, was adjusted to reflect the special dividend declared by the Company on July 22, 2022. Of the 103,275 common shares underlying the as-adjusted option, the reporting person previously reported the exercise of this option as to 50,000 common shares, and the exercise reported on this Form 4 reflects the exercise of the remainder of the option.

Read SEC document
December 12, 2023 Filed Dec 12, 2023 20:25 UTC
REYES JOHNDirector
SaleCommon Shares 19,694 $273.23 $5,380,991.62
Disclosure

SEC source: 0001393311-23-000106 · wk-form4_1702430707.xml · nonDerivative · entry 3

REYES JOHN · CIK 0001227389 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 174,192

F3 · price: Represents weighted average price. These shares were sold at prices ranging between $273.00 and $273.82. Full information regarding the number of shares sold at each separate price will be provided by the reporting person upon request to the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer.

F1 · balance_after: Includes 17,300 restricted stock units and 2,207 deferred stock units.

Read SEC document
December 12, 2023 Filed Dec 12, 2023 20:25 UTC
REYES JOHNDirector
SaleCommon Shares 33,581 $272.82 $9,161,568.42
Disclosure

SEC source: 0001393311-23-000106 · wk-form4_1702430707.xml · nonDerivative · entry 2

REYES JOHN · CIK 0001227389 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 193,886

F2 · price: Represents weighted average price. These shares were sold at prices ranging between $272.58 and $272.99. Full information regarding the number of shares sold at each separate price will be provided by the reporting person upon request to the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer.

F1 · balance_after: Includes 17,300 restricted stock units and 2,207 deferred stock units.

Read SEC document
December 12, 2023 Filed Dec 12, 2023 20:25 UTC
REYES JOHNDirector
Exercise / conversionCommon Shares 53,275 $161.42 $8,599,650.50
Disclosure

SEC source: 0001393311-23-000106 · wk-form4_1702430707.xml · nonDerivative · entry 1

REYES JOHN · CIK 0001227389 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 227,467

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 17,300 restricted stock units and 2,207 deferred stock units.

Read SEC document
December 11, 2023 Filed Dec 12, 2023 10:15 UTC
REYES JOHNDirector
Exercise / conversionStock Option (Right to Buy) · Derivative 50,000 $0.00 Strike: $161.42 $0.00
Disclosure

SEC source: 0001393311-23-000104 · wk-form4_1702394094.xml · derivative · entry 5

REYES JOHN · CIK 0001227389 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,275

Underlying: Common Shares · 50,000 shares

Expires 2024-02-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · security: Stock option granted pursuant to the 2007 Equity and Performance-Based Incentive Compensation Plan. Option vests in five (5) equal annual installments beginning one (1) year from grant date.

F6 · derivative.exercise_price: This option was previously reported as an option for 100,000 shares of common stock at an exercise price of $166.71, but, pursuant to anti-dilution provisions of the Company's 2007 Equity and Performance-Based Incentive Compensation Plan, was adjusted to reflect the special dividend declared by the Company on July 22, 2022.

F6 · shares: This option was previously reported as an option for 100,000 shares of common stock at an exercise price of $166.71, but, pursuant to anti-dilution provisions of the Company's 2007 Equity and Performance-Based Incentive Compensation Plan, was adjusted to reflect the special dividend declared by the Company on July 22, 2022.

F6 · derivative.underlying_shares: This option was previously reported as an option for 100,000 shares of common stock at an exercise price of $166.71, but, pursuant to anti-dilution provisions of the Company's 2007 Equity and Performance-Based Incentive Compensation Plan, was adjusted to reflect the special dividend declared by the Company on July 22, 2022.

F6 · balance_after: This option was previously reported as an option for 100,000 shares of common stock at an exercise price of $166.71, but, pursuant to anti-dilution provisions of the Company's 2007 Equity and Performance-Based Incentive Compensation Plan, was adjusted to reflect the special dividend declared by the Company on July 22, 2022.

Read SEC document
December 11, 2023 Filed Dec 12, 2023 10:15 UTC
REYES JOHNDirector
SaleCommon Shares 1,161 $276.97 $321,562.17
Disclosure

SEC source: 0001393311-23-000104 · wk-form4_1702394094.xml · nonDerivative · entry 4

REYES JOHN · CIK 0001227389 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 174,192

F4 · price: Represents weighted average price. These shares were sold at prices ranging between $276.89 and $277.11. Full information regarding the number of shares sold at each separate price will be provided by the reporting person upon request to the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer.

F1 · balance_after: Includes 17,300 restricted stock units and 2,207 deferred stock units.

Read SEC document
December 11, 2023 Filed Dec 12, 2023 10:15 UTC
REYES JOHNDirector
SaleCommon Shares 36,173 $276.13 $9,988,450.49
Disclosure

SEC source: 0001393311-23-000104 · wk-form4_1702394094.xml · nonDerivative · entry 3

REYES JOHN · CIK 0001227389 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 175,353

F3 · price: Represents weighted average price. These shares were sold at prices ranging between $275.86 and $276.78. Full information regarding the number of shares sold at each separate price will be provided by the reporting person upon request to the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer.

F1 · balance_after: Includes 17,300 restricted stock units and 2,207 deferred stock units.

Read SEC document
December 11, 2023 Filed Dec 12, 2023 10:15 UTC
REYES JOHNDirector
SaleCommon Shares 12,666 $275.46 $3,488,976.36
Disclosure

SEC source: 0001393311-23-000104 · wk-form4_1702394094.xml · nonDerivative · entry 2

REYES JOHN · CIK 0001227389 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 211,526

F2 · price: Represents weighted average price. These shares were sold at prices ranging between $274.81 and $275.79. Full information regarding the number of shares sold at each separate price will be provided by the reporting person upon request to the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer.

F1 · balance_after: Includes 17,300 restricted stock units and 2,207 deferred stock units.

Read SEC document
December 11, 2023 Filed Dec 12, 2023 10:15 UTC
REYES JOHNDirector
Exercise / conversionCommon Shares 50,000 $161.42 $8,071,000.00
Disclosure

SEC source: 0001393311-23-000104 · wk-form4_1702394094.xml · nonDerivative · entry 1

REYES JOHN · CIK 0001227389 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 224,192

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 17,300 restricted stock units and 2,207 deferred stock units.

Read SEC document
November 30, 2023 Filed Dec 1, 2023 20:29 UTC SaleCommon Shares 10,000 $258.09 $2,580,933.00
Disclosure

SEC source: 0001393311-23-000102 · wk-form4_1701462582.xml · nonDerivative · entry 1

HAVNER RONALD L JR · CIK 0001227384 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 310,381

F1 · price: Represents weighted average price. These shares were sold at prices ranging between $258.00 and $258.3925. Full information regarding the number of shares sold at each separate price will be provided by the reporting person upon request to the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer.

F2 · ownership.nature: Ronald L. Havner and LeeAnn R. Havner, Trustee of Havner Family Trust.

Read SEC document
November 20, 2023 Filed Nov 21, 2023 23:35 UTC SaleCommon Shares 5,000 $259.35 $1,296,727.00
Disclosure

SEC source: 0001393311-23-000100 · wk-form4_1700609736.xml · nonDerivative · entry 1

POLADIAN AVEDICK BARUYR · CIK 0001305254 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,163

F1 · price: Represents weighted average price. These shares were sold at prices ranging between $258.90 and $259.68. Full information regarding the number of shares sold at each separate price will be provided by the reporting person upon request to the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer.

Read SEC document
November 10, 2023 Filed Nov 13, 2023 17:57 UTC
Vitan Nathaniel A.Chief Legal Officer
SaleCommon Shares 400 $245.37 $98,146.00
Disclosure

SEC source: 0001393311-23-000098 · wk-form4_1699898263.xml · nonDerivative · entry 1

Vitan Nathaniel A. · CIK 0001774586 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,286

F1 · balance_after: Includes 10,330 restricted stock units.

Read SEC document
September 30, 2023 Filed Oct 3, 2023 19:44 UTC GrantCommon Shares 133 $263.52 $35,048.16
Disclosure

SEC source: 0001062993-23-018775 · form4.xml · nonDerivative · entry 1

SPOGLI RONALD P · CIK 0000916867 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,120

F1 · shares: Grant of fully-vested deferred stock units pursuant to the Company's Non-Management Trustee Compensation and Deferral Program under the Company's 2021 Equity and Performance-Based Incentive Compensation Plan. Each deferred stock unit represents the right to receive one share of the Company's common stock. The number of deferred stock units granted represents the quotient of the dollar amount of the portion of the cash retainers Mr. Spogli has earned for the applicable calendar quarter and elected to be paid in deferred stock units, divided by the Company's closing stock price on the grant date, rounded up to the nearest deferred stock unit. The deferred stock units will be settled in shares of unrestricted common stock (i) in a lump sum on January 1st of the calendar year following Mr. Spogli's separation from service as a trustee or (ii) in a lump sum upon Mr. Spogli's earlier death or disability or upon an earlier change of control of the Company.

F2 · balance_after: Includes 1,957 deferred stock units.

Read SEC document
September 30, 2023 Filed Oct 3, 2023 19:36 UTC GrantCommon Shares 71 $263.52 $18,709.92
Disclosure

SEC source: 0001062993-23-018769 · form4.xml · nonDerivative · entry 1

WILLIAMS PAUL S · CIK 0001236458 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 774

F1 · shares: Grant of fully-vested deferred stock units pursuant to the Company's Non-Management Trustee Compensation and Deferral Program under the Company's 2021 Equity and Performance-Based Incentive Compensation Plan. Each deferred stock unit represents the right to receive one share of the Company's common stock. The number of deferred stock units granted represents the quotient of the dollar amount of the portion of the cash retainers the reporting person has earned for the applicable calendar quarter and elected to be paid in deferred stock units, divided by the Company's closing stock price on the grant date, rounded up to the nearest deferred stock unit. The deferred stock units will be settled in shares of unrestricted common stock (i) in a lump sum following the reporting person's separation from service as a trustee or (ii) in a lump sum upon the reporting person's earlier death or disability or upon an earlier change of control of the Company.

F2 · balance_after: Includes 774 deferred stock units.

Read SEC document
September 30, 2023 Filed Oct 3, 2023 19:42 UTC GrantCommon Shares 114 $263.52 $30,041.28
Disclosure

SEC source: 0001062993-23-018773 · form4.xml · nonDerivative · entry 1

HAVNER RONALD L JR · CIK 0001227384 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,332

F1 · shares: Grant of fully-vested deferred stock units pursuant to the Company's Non-Management Trustee Compensation and Deferral Program under the Company's 2021 Equity and Performance-Based Incentive Compensation Plan. Each deferred stock unit represents the right to receive one share of the Company's common stock. The number of deferred stock units granted represents the quotient of the dollar amount of the portion of the cash retainers the reporting person has earned for the applicable calendar quarter and elected to be paid in deferred stock units, divided by the Company's closing stock price on the grant date, rounded up to the nearest deferred stock unit. The deferred stock units will be settled in shares of unrestricted common stock (i) in a lump sum upon the reporting person's separation from service as a trustee or (ii) in a lump sum upon the reporting person's earlier death or disability or upon an earlier change of control of the Company.

F2 · balance_after: Includes 33,125 restricted stock units and 2,207 deferred stock units. Mr. Havner postponed receipt of 10,000 vested restricted stock units granted February 19, 2015 with an original vesting date of April 1, 2016 in accordance with the following schedule: 10 equal installments over 10 years starting April 1, 2021 to April 1, 2030. 7,000 remain subject to deferred receipt and are also included here.

Read SEC document
September 30, 2023 Filed Oct 3, 2023 15:40 UTC
REYES JOHNDirector
GrantCommon Shares 114 $263.52 $30,041.28
Disclosure

SEC source: 0001062993-23-018772 · form4.xml · nonDerivative · entry 1

REYES JOHN · CIK 0001227389 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 174,192

F1 · shares: Grant of fully-vested deferred stock units pursuant to the Company's Non-Management Trustee Compensation and Deferral Program under the Company's 2021 Equity and Performance-Based Incentive Compensation Plan. Each deferred stock unit represents the right to receive one share of the Company's common stock. The number of deferred stock units granted represents the quotient of the dollar amount of the portion of the cash retainers the reporting person has earned for the applicable calendar quarter and elected to be paid in deferred stock units, divided by the Company's closing stock price on the grant date, rounded up to the nearest deferred stock unit. The deferred stock units will be settled in shares of unrestricted common stock (i) in a lump sum upon the reporting person's separation from service as a trustee or (ii) in a lump sum upon the reporting person's earlier death or disability or upon an earlier change of control of the Company.

F2 · balance_after: Includes 17,300 restricted stock units and 2,207 deferred stock units.

Read SEC document
September 30, 2023 Filed Oct 3, 2023 19:39 UTC GrantCommon Shares 140 $263.52 $36,892.80
Disclosure

SEC source: 0001062993-23-018771 · form4.xml · nonDerivative · entry 1

NEITHERCUT DAVID J · CIK 0001219726 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,408

F1 · shares: Grant of fully-vested deferred stock units pursuant to the Company's Non-Management Trustee Compensation and Deferral Program under the Company's 2021 Equity and Performance-Based Incentive Compensation Plan. Each deferred stock unit represents the right to receive one share of the Company's common stock. The number of deferred stock units granted represents the quotient of the dollar amount of the portion of the cash retainers the reporting person has earned for the applicable calendar quarter and elected to be paid in deferred stock units, divided by the Company's closing stock price on the grant date, rounded up to the nearest deferred stock unit. The deferred stock units will be settled in shares of unrestricted common stock (i) in a lump sum on January 1st of the calendar year following the tenth anniversary of the grant date or (ii) in a lump sum upon the reporting person's earlier death or disability or upon an earlier change of control of the Company.

F2 · balance_after: Includes 1,408 deferred stock units.

Read SEC document
September 30, 2023 Filed Oct 3, 2023 19:43 UTC GrantCommon Shares 121 $263.52 $31,885.92
Disclosure

SEC source: 0001062993-23-018774 · form4.xml · nonDerivative · entry 1

Owen Rebecca L · CIK 0001331684 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 769

F1 · shares: Grant of unrestricted shares of the Company's common stock pursuant to the Company's Non-Management Trustee Compensation and Deferral Program under the Company's 2021 Equity and Performance-Based Incentive Compensation Plan. The number of shares granted represents the quotient of the dollar amount of the portion of the cash retainers the reporting person has earned for the applicable calendar quarter and elected to be paid in shares of common stock, divided by the Company's closing stock price on the grant date, rounded up to the nearest share.

Read SEC document
September 30, 2023 Filed Oct 3, 2023 19:38 UTC
Mitra ShankhDirector
GrantCommon Shares 121 $263.52 $31,885.92
Disclosure

SEC source: 0001062993-23-018770 · form4.xml · nonDerivative · entry 1

Mitra Shankh · CIK 0001698445 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,890

F1 · shares: Grant of unrestricted shares of the Company's common stock pursuant to the Company's Non-Management Trustee Compensation and Deferral Program under the Company's 2021 Equity and Performance-Based Incentive Compensation Plan. The number of shares granted represents the quotient of the dollar amount of the portion of the cash retainers the reporting person has earned for the applicable calendar quarter and elected to be paid in shares of common stock, divided by the Company's closing stock price on the grant date, rounded up to the nearest share.

F2 · balance_after: Includes 432 deferred stock units.

Read SEC document
August 04, 2023 Filed Aug 5, 2023 00:23 UTC
Johnson NataliaChief Administrative Officer
Tax withholdingCommon Shares 199 $275.69 $54,862.31
Disclosure

SEC source: 0001393311-23-000082 · wk-form4_1691194975.xml · nonDerivative · entry 1

Johnson Natalia · CIK 0001726283 · Chief Administrative Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,987

F1 · balance_after: Includes 12,390 restricted stock units.

Read SEC document
June 30, 2023 Filed Jul 3, 2023 22:54 UTC GrantCommon Shares 120 $291.88 $35,025.60
Disclosure

SEC source: 0001393311-23-000063 · wk-form4_1688424876.xml · nonDerivative · entry 1

SPOGLI RONALD P · CIK 0000916867 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,987

F1 · shares: Grant of fully-vested deferred stock units pursuant to the Company's Non-Management Trustee Compensation and Deferral Program under the Company's 2021 Equity and Performance-Based Incentive Compensation Plan. Each deferred stock unit represents the right to receive one share of the Company's common stock. The number of deferred stock units granted represents the quotient of the dollar amount of the portion of the cash retainers the reporting person has earned for the applicable calendar quarter and elected to be paid in deferred stock units, divided by the Company's closing stock price on the grant date, rounded up to the nearest deferred stock unit. The deferred stock units will be settled in shares of unrestricted common stock (i) in a lump sum on January 1st of the calendar year following the reporting person's separation from service as a trustee or (ii) in a lump sum upon the reporting person's earlier death or disability or upon an earlier change of control of the Company.

F2 · balance_after: Includes 1,824 deferred stock units.

Read SEC document
June 30, 2023 Filed Jul 3, 2023 22:57 UTC GrantCommon Shares 64 $291.88 $18,680.32
Disclosure

SEC source: 0001393311-23-000067 · wk-form4_1688425017.xml · nonDerivative · entry 1

WILLIAMS PAUL S · CIK 0001236458 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 703

F1 · shares: Grant of fully-vested deferred stock units pursuant to the Company's Non-Management Trustee Compensation and Deferral Program under the Company's 2021 Equity and Performance-Based Incentive Compensation Plan. Each deferred stock unit represents the right to receive one share of the Company's common stock. The number of deferred stock units granted represents the quotient of the dollar amount of the portion of the cash retainers the reporting person has earned for the applicable calendar quarter and elected to be paid in deferred stock units, divided by the Company's closing stock price on the grant date, rounded up to the nearest deferred stock unit. The deferred stock units will be settled in shares of unrestricted common stock (i) in a lump sum following the reporting person's separation from service as a trustee or (ii) in a lump sum upon the reporting person's earlier death or disability or upon an earlier change of control of the Company.

F2 · balance_after: Includes 703 deferred stock units.

Read SEC document
June 30, 2023 Filed Jul 3, 2023 22:52 UTC GrantCommon Shares 103 $291.88 $30,063.64
Disclosure

SEC source: 0001393311-23-000059 · wk-form4_1688424732.xml · nonDerivative · entry 1

HAVNER RONALD L JR · CIK 0001227384 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,218

F1 · shares: Grant of fully-vested deferred stock units pursuant to the Company's Non-Management Trustee Compensation and Deferral Program under the Company's 2021 Equity and Performance-Based Incentive Compensation Plan. Each deferred stock unit represents the right to receive one share of the Company's common stock. The number of deferred stock units granted represents the quotient of the dollar amount of the portion of the cash retainers the reporting person has earned for the applicable calendar quarter and elected to be paid in deferred stock units, divided by the Company's closing stock price on the grant date, rounded up to the nearest deferred stock unit. The deferred stock units will be settled in shares of unrestricted common stock (i) in a lump sum upon the reporting person's separation from service as a trustee or (ii) in a lump sum upon the reporting person's earlier death or disability or upon an earlier change of control of the Company.

F2 · balance_after: Includes 33,125 restricted stock units and 2,093 deferred stock units. Mr. Havner postponed receipt of 10,000 vested restricted stock units granted February 19, 2015 with an original vesting date of April 1, 2016 in accordance with the following schedule: 10 equal installments over 10 years starting April 1, 2021 to April 1, 2030. 7,000 remain subject to deferred receipt and are also included here.

Read SEC document
June 30, 2023 Filed Jul 3, 2023 18:53 UTC
REYES JOHNDirector
GrantCommon Shares 103 $291.88 $30,063.64
Disclosure

SEC source: 0001393311-23-000061 · wk-form4_1688424807.xml · nonDerivative · entry 1

REYES JOHN · CIK 0001227389 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 174,078

F1 · shares: Grant of fully-vested deferred stock units pursuant to the Company's Non-Management Trustee Compensation and Deferral Program under the Company's 2021 Equity and Performance-Based Incentive Compensation Plan. Each deferred stock unit represents the right to receive one share of the Company's common stock. The number of deferred stock units granted represents the quotient of the dollar amount of the portion of the cash retainers the reporting person has earned for the applicable calendar quarter and elected to be paid in deferred stock units, divided by the Company's closing stock price on the grant date, rounded up to the nearest deferred stock unit. The deferred stock units will be settled in shares of unrestricted common stock (i) in a lump sum upon the reporting person's separation from service as a trustee or (ii) in a lump sum upon the reporting person's earlier death or disability or upon an earlier change of control of the Company.

F2 · balance_after: Includes 17,300 restricted stock units and 2,093 deferred stock units.

Read SEC document
June 30, 2023 Filed Jul 3, 2023 22:56 UTC GrantCommon Shares 127 $291.88 $37,068.76
Disclosure

SEC source: 0001393311-23-000065 · wk-form4_1688424953.xml · nonDerivative · entry 1

NEITHERCUT DAVID J · CIK 0001219726 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,268

F1 · shares: Grant of fully-vested deferred stock units pursuant to the Company's Non-Management Trustee Compensation and Deferral Program under the Company's 2021 Equity and Performance-Based Incentive Compensation Plan. Each deferred stock unit represents the right to receive one share of the Company's common stock. The number of deferred stock units granted represents the quotient of the dollar amount of the portion of the cash retainers the reporting person has earned for the applicable calendar quarter and elected to be paid in deferred stock units, divided by the Company's closing stock price on the grant date, rounded up to the nearest deferred stock unit. The deferred stock units will be settled in shares of unrestricted common stock (i) in a lump sum on January 1st of the calendar year following the tenth anniversary of the grant date or (ii) in a lump sum upon the reporting person's earlier death or disability or upon an earlier change of control of the Company.

F2 · balance_after: Includes 1,268 deferred stock units.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.